Technology

Technology Platforms

Cell and Gene Therapy

Gene therapy attempts to treat illness or strengthen your body's resistance to illness by replacing a damaged gene or adding a new gene. Numerous disorders, including cancer, cystic fibrosis, heart disease, diabetes, haemophilia, and AIDS, could be treated by gene therapy.
Cell and gene therapy (CGT) has the potential to revolutionise medicine by offering long-term and possibly curative treatment options for a variety of illnesses, including the dreaded malignancies, genetic disorders, autoimmune diseases, and many more.
In order to treat or halt disease, gene therapy entails changing the genes in our body's cells. Our DNA, which regulates a large portion of body form and function, including making us taller and controlling our body systems, is found in our genes. Genes that do not function properly can bring on disease.

Capabilities

We are developing a Cell and Gene Therapy Proof of Concept right now. We have an advantage in tackling problems related to the development of biotech/biological product(s) thanks to our domain knowledge and expertise in research, process development, and commercial scale. Companies in the biopharmaceutical and biotech industries can benefit from our knowledge and support for their products, procedures, and quality management system (QMS).

CAR T-cell treatment

It is a form of cancer immunotherapy that employs immune cells called T cells that have been genetically modified in a lab to improve their capacity to detect and eliminate cancer cells.
CAR T-cells is a type of treatment wherein the patient's T cells, an immune cell type, are altered in a lab so they will adhere to and kill cancer cells.
A cutting-edge new pillar in immune cell therapy for cancer is chimeric antigen receptor (CAR)-T cell therapy. It has had impressive clinical results in patients with lymphoma or B-cell leukaemia.

Capabilities

We are developing a Cell and Gene Therapy Proof of Concept right now. We have an advantage in tackling problems related to the development of biotech/biological product(s) thanks to our domain knowledge and expertise in research, process development, and commercial scale. Companies in the biopharmaceutical and biotech industries can benefit from our knowledge and support for their products, procedures, and quality management system (QMS).

Vaccines technologies

Bacterial and Viral vaccines technologies Recombinant & conjugate Polysaccharide vaccines technologies Invigorate Bio wants to use platform technologies to develop a variety of vaccines, including the Pneumococcal conjugate vaccine (20 valent), Hib-TT conjugate vaccine, Meningococcal conjugate vaccine, Hepatitis B vaccine, rTyphoid, Dengue, JE, mRNA vaccine, influenza vaccine, etc. to support India's One Health mission and make healthcare accessible to everyone.
Platform technologies facilitate the production of products in greater quantities and at lower costs than traditional approaches.
To maintain our livestock healthy and productive, Invigorate Bio is keenly interested in developing a portfolio of veterinary and poultry vaccines (again, to mention a few: FMD, rAnthrax, Brucella, Rabies, PPR, Fowl pox, New Castle disease, and Marek's disease).

Capabilities

With platform technologies, Invigorate Bio has deep knowledge and competence in research, process development, and commercial scale production of several vaccines, such as the 20-valent pneumococcal conjugate vaccine, the Hib-TT conjugate vaccine, the meningococcal conjugate vaccine, and the hepatitis B vaccine.

Recombinant Enzymes

About 85% of the enzymes used in the diagnostics sector are imported into India. Aiming to create recombinant enzymes such creatinase, creatininase, sarcosine oxydase, uricase FAD dependent glucose dehydrogenase, etc. for the diagnostics business, Invigorate sees a significant chance to make the nation self-sufficient in this area.
These enzymes are mostly employed in the testing of lipid metabolism, liver function, pancreatic function, kidney function, and diabetes.

Capabilities

Utilising platform technologies, Invigorate Bio has extensive knowledge and competence in the development of recombinant enzymes.